Gene · 64115
Papers2,513
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,513
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical Next Generation Sequencing Application in Mesothelioma: Finding a Golden Needle in the Haystack. | Cancers (Basel) | 2023 | 38136262 | PubTator, text mining | PubMed |
| PD-1 and PD-L1: architects of immune symphony and immunotherapy breakthroughs in cancer treatment. | Front Immunol | 2023 | 38106415 | PubTator, text mining | PubMed |
| Harnessing immunotherapy for brain metastases: insights into tumor-brain microenvironment interactions and emerging treatment modalities. | J Hematol Oncol | 2023 | 38104104 | PubTator, text mining | PubMed |
| Mapping the protein-protein interactome in the tumor immune microenvironment. | Antib Ther | 2023 | 38098892 | PubTator, text mining | PubMed |
| Aldehyde dehydrogenase 2-mediated aldehyde metabolism promotes tumor immune evasion by regulating the NOD/VISTA axis. | J Immunother Cancer | 2023 | 38088186 | PubTator, text mining | PubMed |
| Molecular and temporal control of restimulation-induced cell death (RICD) in T lymphocytes. | Front Cell Death | 2023 | 38074985 | PubTator, text mining | PubMed |
| Developing a novel SARS-CoV-2 risk index to predict the prognostic and therapeutic effects in acute myeloid leukemia. | Heliyon | 2023 | 38074856 | PubTator, text mining | PubMed |
| Editorial: Diagnostic, prognostic and predictive factors of response in the era of precision oncology in breast cancer. | Front Oncol | 2023 | 38074662 | PubTator, text mining | PubMed |
| Pre-treatment inflamed tumor immune microenvironment is associated with FOLFIRINOX response in pancreatic cancer. | Front Oncol | 2023 | 38074633 | PubTator, text mining | PubMed |
| Preliminary analysis of immune-related markers in thymic carcinoid. | J Transl Med | 2023 | 38071307 | PubTator, text mining | PubMed |
| Biomarkers for Salvage Therapy in Testicular Germ Cell Tumors. | Int J Mol Sci | 2023 | 38069192 | PubTator, text mining | PubMed |
| Modulation of CD8+ T Cell Responses by Radiotherapy-Current Evidence and Rationale for Combination with Immune Checkpoint Inhibitors. | Int J Mol Sci | 2023 | 38069014 | PubTator, text mining | PubMed |
| Dynamic profiling of immune microenvironment during anti-PD-1 immunotherapy for head and neck squamous cell carcinoma: the IPRICE study. | BMC Cancer | 2023 | 38066522 | PubTator, text mining | PubMed |
| Complex in vitro Model: A Transformative Model in Drug Development and Precision Medicine. | Clin Transl Sci | 2023 | 38062923 | PubTator, text mining | PubMed |
| Development and evaluation of a risk score model based on a WNT score gene-associated signature for predicting the clinical outcome and the tumour microenvironment of hepatocellular carcinoma. | Int J Immunopathol Pharmacol | 2023 | 38054921 | PubTator, text mining | PubMed |
| Biomarkers and experimental models for cancer immunology investigation. | MedComm (2020) | 2023 | 38045830 | PubTator, text mining | PubMed |
| Targeted spatial proteomic analysis of CD8+ T- and myeloid cells in tonsillar cancer. | Front Oncol | 2023 | 38044986 | PubTator, text mining | PubMed |
| Tumor-associated macrophages: an effective player of the tumor microenvironment. | Front Immunol | 2023 | 38035101 | PubTator, text mining | PubMed |
| A comprehensive cuproptosis score and associated gene signatures reveal prognostic and immunological features of idiopathic pulmonary fibrosis. | Front Immunol | 2023 | 38035073 | PubTator, text mining | PubMed |
| OSM May Serve as a Biomarker of Poor Prognosis in Clear Cell Renal Cell Carcinoma and Promote Tumor Cell Invasion and Migration. | Int J Genomics | 2023 | 38034950 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64115/papers?page=17